GAMBALE, CARLA
 Distribuzione geografica
Continente #
NA - Nord America 841
EU - Europa 780
AS - Asia 380
AF - Africa 72
SA - Sud America 48
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.122
Nazione #
US - Stati Uniti d'America 826
IT - Italia 326
CN - Cina 175
DE - Germania 159
SG - Singapore 120
AT - Austria 78
SE - Svezia 72
CI - Costa d'Avorio 43
BG - Bulgaria 38
BR - Brasile 36
GB - Regno Unito 33
HK - Hong Kong 23
SN - Senegal 22
RU - Federazione Russa 21
TR - Turchia 20
FI - Finlandia 17
VN - Vietnam 17
CA - Canada 12
NL - Olanda 8
PL - Polonia 8
IN - India 7
IR - Iran 5
MG - Madagascar 5
UA - Ucraina 5
AR - Argentina 4
CZ - Repubblica Ceca 4
CL - Cile 3
CY - Cipro 3
EC - Ecuador 3
AZ - Azerbaigian 2
BE - Belgio 2
ES - Italia 2
FR - Francia 2
JP - Giappone 2
KR - Corea 2
SV - El Salvador 2
BO - Bolivia 1
CH - Svizzera 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
IE - Irlanda 1
IQ - Iraq 1
LB - Libano 1
LV - Lettonia 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 2.122
Città #
Santa Clara 135
Chandler 126
Milan 99
Shanghai 75
Vienna 73
Singapore 62
Ashburn 50
New York 50
Fairfield 47
Abidjan 43
Pisa 43
Sofia 38
Boardman 31
Seattle 29
Wilmington 26
Munich 25
Rome 25
Cambridge 23
Woodbridge 23
Dakar 22
Florence 22
Princeton 22
Houston 21
Beijing 20
Lawrence 19
Frankfurt am Main 16
Hong Kong 15
Helsinki 13
Dong Ket 10
Fuzhou 10
Medford 10
Serra 10
Boulder 9
Cascina 9
London 9
Ann Arbor 8
Istanbul 8
San Diego 8
Livorno 7
Lucca 7
Ogden 7
Quanzhou 7
Ottawa 6
Vicopisano 6
Antananarivo 5
Bremen 5
Los Angeles 5
Nanjing 5
Samsun 5
Xiamen 5
Brno 4
Chengdu 4
Dearborn 4
Nuremberg 4
Washington 4
Zhengzhou 4
Atakum 3
Bologna 3
Des Moines 3
Fortaleza 3
Guangzhou 3
Jiaxing 3
Jinan 3
Kyiv 3
Norwalk 3
Rio de Janeiro 3
Santiago 3
Toronto 3
Assisi 2
Baku 2
Bari 2
Baton Rouge 2
Belo Horizonte 2
Brussels 2
Calcinaia 2
Cellole 2
Central District 2
Haikou 2
Hebei 2
Lappeenranta 2
Monte Compatri 2
Montreal 2
Monza 2
Naples 2
Quito 2
Redwood City 2
San Salvador 2
São Paulo 2
Tianjin 2
Yangquan 2
Yonkers 2
Afrânio 1
Afyonkarahisar 1
Assis 1
Athens 1
Basra 1
Beirut 1
Belford Roxo 1
Boydton 1
Brasília 1
Totale 1.469
Nome #
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 200
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 160
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 126
Potential impact of BMI on the aggressiveness of presentation and clinical outcome of Differentiated Thyroid Cancer 111
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). 107
Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I 104
Recombinant Human Thyrotropin Stimulation Thyroglobulin (rhTSH-Tg) test can identify false serum tg due to heterophilic antibodies in differentiated thyroid cancer (DTC) patients 99
The Thymic Hyperplasia (TH) And Biochemical Persistence Of Disease In Patients With Differentiated Thyroid Carcinoma (DTC) 95
Radioiodine remnant ablation (RRA) Impact on the dynamic risk of restratification in the short-term follow-up of patients with differentiated thyroid cancer (DTC). 93
Predictive Value Of High Sensitive Thyroglobulin Assay (USTG) And Neck Ultrasonography (US) At The Time Of Remnant Ablation On Lt-4 Therapy In Patients With Low And Intermediate Risk Differentiated Thyroid Cancer (DTC) 84
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). 77
Systemic treatment of advanced, metastatic, medullary thyroid carcinoma 77
Thyroid cancers: From surgery to current and future systemic therapies through their molecular identities 76
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 76
Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma 74
Active surveillance in ret gene carriers belonging to families with multiple endocrine neoplasia 63
Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment 57
Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma 56
Management and follow-up of differentiated thyroid cancer not submitted to radioiodine treatment: a systematic review 54
Effect of Pregnancy and Menopause on Micropapillary Thyroid Carcinomas During Active Surveillance 40
Chylous effusions in advanced medullary thyroid cancer patients treated with selpercatinib 40
Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine 39
Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome 38
Hypothesizing a role of ret hyperactivation on weight control in patients with type 2A multiple endocrine neoplasia (MEN2A) 35
Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response 30
Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients 28
Ultrasound features and risk stratification system in NIFT-P and other follicular-patterned thyroid tumors 27
NF1 Gene Inactivation Acts as Tumor Driver in RET/RAS Negative Medullary Thyroid Carcinomas 25
Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature 19
BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review 19
Erectile dysfunction in patients treated with selpercatinib for RET altered thyroid cancer 19
Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone 14
Timing and Ideal Patient for an Appropriate Search for Somatic RET Mutation in Medullary Thyroid Cancer 14
Insights into Ultrasound Features and Risk Stratification Systems in Pediatric Patients with Thyroid Nodules 12
Fluctuating obliterative bronchiolitis in RET-mutant medullary thyroid cancer patient treated with selpercatinib 10
Somatic RET Indels in Sporadic Medullary Thyroid Cancer: Prevalence and Response to Selpercatinib 7
Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma 7
The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma 1
Totale 2.213
Categoria #
all - tutte 9.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020112 0 0 0 0 0 0 0 13 22 24 47 6
2020/2021149 18 5 15 2 8 21 9 7 8 11 23 22
2021/2022167 1 4 5 2 31 28 5 8 9 7 13 54
2022/2023497 32 56 51 36 54 54 20 44 109 5 29 7
2023/2024468 42 56 70 39 62 76 21 7 13 9 30 43
2024/2025626 26 43 28 82 148 126 129 44 0 0 0 0
Totale 2.213